Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
108 0 |
Căutarea după subiecte similare conform CZU |
616.24-002.5:615.015.8]-022.16-085.281-039.71-053.2/.6 (1) |
Patologia sistemului respirator. Tulburări ale organelor de respiraţie (760) |
Farmacologie. Terapeutică. Toxicologie (1598) |
SM ISO690:2012 SAKHELASHVILI-BIL, Olha, PLATONOVA, Iryna. The efficiency of immune modulator BIVEL for the prevention of pulmonary tuberculosis in exposed children from the multidrug-resistant tuberculosis sites. In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2023, nr. 3(77), pp. 94-102. ISSN 1857-0011. DOI: https://doi.org/10.52692/1857-0011.2023.3-77.15 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale | ||||||
Numărul 3(77) / 2023 / ISSN 1857-0011 | ||||||
|
||||||
DOI:https://doi.org/10.52692/1857-0011.2023.3-77.15 | ||||||
CZU: 616.24-002.5:615.015.8]-022.16-085.281-039.71-053.2/.6 | ||||||
Pag. 94-102 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
120 exposed children/adolescents (75 children and 45 adolescents) from the multi-drug resistant tuberculosis sites underwent the complex clinical radiological and immunological examination. Insignificant functional disorders of cellular response (immunoregulatory processes) caused by the prevalence of suppressor and cytotoxic reactions by 1.3 times and by the prevalence of pro-inflammatory cytokines in the regulatory system (2.0 times above the norm, TNF-α/IL 10.0. р<0.01) were revealed in the infected children/adolescents from the multi-drug resistant tuberculosis sites, while their СD3+. СD3+СD4+. СD3+СD8+ were within norm. The evident disorders of the regulatory system and cell immune system were eliminated after the completion of the autumn-spring BI-V course. The non-specific immune regulator BI-V is efficient for the prevention of multi-drug resistant tuberculosis for the exposed children/adolescents from the multi-drug tuberculosis sites. Consequently, the latent TB infection grew into the active form by 2.8 times less often in the children that took BI-V as compared to the infected children who did not take the drug. |
||||||
Cuvinte-cheie BIVEL immunomodulator, pulmonary tuberculosis in children, Cellular immunity, tuberculosis, иммуномодулятор БИВЕЛ, туберкулез легких у детей, клеточный иммунитет, туберкулез, imunomodulatorul BIVEL, tuberculoza pulmonară la copii, imunitate celulară, tuberculoza |
||||||
|